Onconetix Files Prospectus For Resale Of Up To 100M Shares Issuable Upon Conversion Of Series F Preferred Stock, Or 2,532% Of Shares Outstanding
Share
Why It Matters
Onconetix is letting some investors convert their special stock into regular shares—a huge number, way more than shares out now. This is a normal legal filing, but watch how the regular stock price reacts since so many new shares could join the market.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.